Barclays’s Insulet PODD Stock Holding History

Barclays’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Sell	4,900 -4,800	-49%	-$1.21M	﹤0.01%	2744
2025 Q4	$2.76M	Hold	9,700	–	–	﹤0.01%	2697
2025 Q3	$2.99M	Buy	9,700 +8,800	+978%	+$2.76M	﹤0.01%	2570
2025 Q2	$283K	Buy	+900	New	+$260K	﹤0.01%	4078
2024 Q4	–	Sell	-2,100	Closed	-$489K	–	5433
2024 Q3	$489K	Buy	+2,100	New	+$431K	﹤0.01%	3787
2024 Q2	–	Sell	-2,300	Closed	-$394K	–	5205
2024 Q1	$394K	Sell	2,300 -2,300	-50%	-$429K	﹤0.01%	3734
2023 Q4	$998K	Buy	+4,600	New	+$789K	﹤0.01%	3435

Other funds holding PODD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Barclays's PODD Position: Q1 2026 in Review

Barclays reduced its Insulet (PODD) stake by 43% in Q1 2026, selling an estimated $24.5M and leaving 128,512 shares worth $27M. The position accounts for 0.01% of the portfolio, ranked #975.

Barclays first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $73.1M in Q1 2024. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

Barclays held 128,512 shares of Insulet worth $27M as of Q1 2026.
Barclays sold 97,377 Insulet shares in Q1 2026, an estimated $24.5M.
Insulet made up 0.01% of Barclays's portfolio in Q1 2026, its #975 holding.
Barclays first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
Barclays's Insulet position peaked at $73.1M in Q1 2024.
784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.